These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 36341328)

  • 41. Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer.
    Li C; Xiao Y; Cao H; Chen Y; Li S; Yin F
    Biol Trace Elem Res; 2024 Jan; 202(1):99-110. PubMed ID: 37155084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer.
    Li J; Wu F; Li C; Sun S; Feng C; Wu H; Chen X; Wang W; Zhang Y; Liu M; Liu X; Cai Y; Jia Y; Qiao H; Zhang Y; Zhang S
    Front Genet; 2022; 13():977322. PubMed ID: 36226193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
    Xu Q; Chen S; Hu Y; Huang W
    Front Immunol; 2021; 12():711433. PubMed ID: 34512634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
    Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
    Front Immunol; 2022; 13():954440. PubMed ID: 36059510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model.
    Cui J; Xiong Y; Liu Y; Sun M; Gu X; Zhong L; Hong X; Liu L
    Biomed Res Int; 2022; 2022():7406636. PubMed ID: 36588537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity.
    Wang H; Li J; Zi X; Yuan X
    Front Oncol; 2023; 13():1116305. PubMed ID: 36895470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
    Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
    Front Immunol; 2022; 13():998236. PubMed ID: 36110851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
    Huang Y; Yin D; Wu L
    Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.
    Zhang S; Yu S; Duan H; Xia W; Wang C; Shen H
    Front Genet; 2022; 13():997573. PubMed ID: 36263417
    [No Abstract]   [Full Text] [Related]  

  • 51. Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma.
    Li M; Song Q; Bai Y; Hua F; Wu T; Liu J
    Front Pharmacol; 2022; 13():992431. PubMed ID: 36263140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer.
    Wang X; Zuo X; Hu X; Liu Y; Wang Z; Chan S; Sun R; Han Q; Yu Z; Wang M; Zhang H; Chen W
    Front Oncol; 2023; 13():927608. PubMed ID: 37007145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma.
    Zhang B; Wang Q; Zhang T; Zheng Z; Lin Z; Zhou S; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y
    Front Cell Dev Biol; 2023; 11():1159355. PubMed ID: 37152283
    [No Abstract]   [Full Text] [Related]  

  • 54. Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma.
    Liu D; Yang F; Zhang T; Mao R
    J Transl Med; 2023 Jan; 21(1):57. PubMed ID: 36717900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma.
    Wang Y; Zhang C; Ji C; Jin W; He X; Yu S; Guo R
    Front Genet; 2022; 13():1006938. PubMed ID: 36313439
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y; Zhang Q; Zhang H; Kong F
    Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients.
    Yang H; Yang J; Bian H; Wang X
    Front Pediatr; 2022; 10():1049858. PubMed ID: 36568423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma.
    Zhang L; Xu J; Chu X; Zhang H; Yao X; Zhang J; Guo Y
    BMC Bioinformatics; 2022 Nov; 23(1):485. PubMed ID: 36384423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer.
    Wang XX; Deng SZ; Wu LH; Liu QQ; Zheng G; Du K; Dou QY; Zheng J; Zhang HM
    ACS Omega; 2023 Mar; 8(12):10851-10862. PubMed ID: 37008098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cuproptosis-associated genes and immune microenvironment characterization in breast cancer.
    Shen L; He Y; Fang C; Qiu H; Chen Q; Huang F; Wu Z
    Medicine (Baltimore); 2022 Dec; 101(50):e32301. PubMed ID: 36550822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.